PROSTIN E2, created in 2000 (United States), from
1125 sister brands
and 17478 competing brands.
The PROSTIN E2 brand is owned by Pfizer Inc, a company listed in New York.
PROSTIN E2 is part of the Drug Manufacturers activity sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.